Literature DB >> 31189570

Skint8, a Novel B7 Family-Related Molecule, Negatively Regulates T Cell Responses.

Yujun Lin1,2, Cheng Cui1, Min Su1, Xiaohong Tian1, Yuanmao Huang1, Jin Zhao1, Laijun Lai3,4.   

Abstract

Immune responses are tightly controlled by T cell costimulatory and coinhibitory molecules. In this study, we identify Skint8 as a new member of the T cell coinhibitory group, whose extracellular domains share significant homology with existing B7 family members. Skint8 mRNA is expressed in resting and activated B cells, monocytes, and CD4 T cells. The Skint8 putative receptor is expressed on activated CD4 and CD8 T cells, B cells, monocytes and dendritic cells. Recombinant Skint8-IgG Fc fusion protein inhibits T cell proliferation, activation, and cytokine production in vitro. In vivo administration of Skint8-IgG Fc reduces T cell activation and alleviates experimental autoimmune encephalomyelitis in mice. The findings broaden our understanding of the regulation of immune responses and may have implications for treating immune-related diseases.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31189570      PMCID: PMC6615975          DOI: 10.4049/jimmunol.1800639

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.

Authors:  H Dong; G Zhu; K Tamada; L Chen
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation.

Authors:  Thang Nguyen; Xikui K Liu; Yongliang Zhang; Chen Dong
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

3.  Characterization of B7S3 as a novel negative regulator of T cells.

Authors:  Yang Yang; Xikui K Liu; Thang Nguyen; Caroline Bishop; Daniel Graf; Chen Dong
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

4.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Authors:  Y Latchman; C R Wood; T Chernova; D Chaudhary; M Borde; I Chernova; Y Iwai; A J Long; J A Brown; R Nunes; E A Greenfield; K Bourque; V A Boussiotis; L L Carter; B M Carreno; N Malenkovich; H Nishimura; T Okazaki; T Honjo; A H Sharpe; G J Freeman
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

5.  BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation.

Authors:  Heather A Arnett; Sabine S Escobar; Eva Gonzalez-Suarez; Alison L Budelsky; Lori A Steffen; Norman Boiani; Ming Zhang; Gerald Siu; Avery W Brewer; Joanne L Viney
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

6.  HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.

Authors:  Ruihua Zhao; Jordan M Chinai; Susan Buhl; Lisa Scandiuzzi; Anjana Ray; Hyungjun Jeon; Kim C Ohaegbulam; Kaya Ghosh; Aimin Zhao; Matthew D Scharff; Xingxing Zang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

7.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

8.  BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.

Authors:  Andrei I Chapoval; Glennda Smithson; Linda Brunick; Mehdi Mesri; Ferenc L Boldog; David Andrew; Nikolai V Khramtsov; Elena A Feshchenko; Gary C Starling; Peter S Mezes
Journal:  Mol Immunol       Date:  2013-12       Impact factor: 4.407

Review 9.  Butyrophilins: an emerging family of immune regulators.

Authors:  Lucie Abeler-Dörner; Mahima Swamy; Gareth Williams; Adrian C Hayday; Anna Bas
Journal:  Trends Immunol       Date:  2011-10-24       Impact factor: 16.687

Review 10.  Novel Immune Check-Point Regulators in Tolerance Maintenance.

Authors:  Yanxia Guo; Adele Y Wang
Journal:  Front Immunol       Date:  2015-08-18       Impact factor: 7.561

View more
  2 in total

1.  Recombinant CD300c-Ig fusion protein attenuates collagen-induced arthritis in mice.

Authors:  Haiyan Liu; Jin Zhao; Min Su; Xiaohong Tian; Laijun Lai
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.580

2.  BTN2A2 protein negatively regulates T cells to ameliorate collagen-induced arthritis in mice.

Authors:  Xueping He; Rong Hu; Peng Luo; Jie Gao; Wenjiang Yang; Jiaju Li; Youjiao Huang; Feng Han; Laijun Lai; Min Su
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.